ImmunityBio Reports Record Q2 2026 Net Product Revenue of $50.7 Million, Up 92% Year-Over-Year; First-Half Revenue Up 121% to $94.8 Million
Business Wire•04/08/2026•07:30 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.